Lyell Immunopharma, Inc. LYEL
NASDAQ · United States · Health Technology
$9.26-0.15 (-1.59%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -1.92 | -1.90 | -1.1% | $4.00K | +10.3% | -7.7%$14.88→$13.74 |
| Q2 2026 | 2026-08-06 | -1.92 | -1.94 | +1.0% | — | — | +9.4%$13.45→$14.71 |
| Q1 2026 | 2026-05-06 | -1.10 | -2.78 | +60.4% | — | — | -2.7%$20.62→$20.06 |
| Q4 2025 | 2026-03-12 | -7.68 | -2.23 | -244.4% | — | — | -15.5%$25.14→$21.25 |
| Q3 2025 | 2025-11-12 | -2.13 | -2.81 | +24.2% | — | — | +0.9%$17.25→$17.41 |
| Q4 2024 | 2025-03-11 | -3.44 | -2.60 | -32.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.